| 000 | 01762 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518023409.0 | ||
| 264 | 0 | _c20200929 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/s41598-018-38322-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Pan | |
| 245 | 0 | 0 |
_aModulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn's Disease in a Three-dimensional Cell Culture Model. _h[electronic resource] |
| 260 |
_bScientific reports _c02 2019 |
||
| 300 |
_a2030 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdalimumab _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnthracenes _xpharmacology |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 |
_aCell Culture Techniques _xmethods |
| 650 | 0 | 4 |
_aCell Membrane Permeability _xdrug effects |
| 650 | 0 | 4 |
_aCrohn Disease _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
| 650 | 0 | 4 |
_aIntestines _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOccludin _xmetabolism |
| 650 | 0 | 4 |
_aPermeability _xdrug effects |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aPlasma _xmetabolism |
| 650 | 0 | 4 |
_aTight Junctions _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 650 | 0 | 4 |
_aZonula Occludens-1 Protein _xmetabolism |
| 700 | 1 | _aElamin, Elhaseen | |
| 700 | 1 | _aElizalde, Montserrat | |
| 700 | 1 | _aBours, Paul P H A | |
| 700 | 1 | _aPierik, Marieke J | |
| 700 | 1 | _aMasclee, Ad A M | |
| 700 | 1 | _aJonkers, Daisy M A E | |
| 773 | 0 |
_tScientific reports _gvol. 9 _gno. 1 _gp. 2030 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-018-38322-8 _zAvailable from publisher's website |
| 999 |
_c29374156 _d29374156 |
||